Diabetic Retinopathy
Kurzinformation
inkl. MwSt. Versandinformationen
Artikel zZt. nicht lieferbar
Artikel zZt. nicht lieferbar

Beschreibung
A well-illustrated and comprehensive analysis of the treatment of diabetic retinopathy, this book covers current treatment options and guidelines, whilst also providing a detailed discussion of emerging therapeutic targets. Existing therapeutic options are covered in depth, with a major focus on anti-vascular endothelial growth factor drugs and sustained release corticosteroids, including a review of trial results supporting current treatment guidelines. The use of agents off-label is also discussed. Controversial topics are discussed in detail with an emphasis on helping the reader make informed decisions, particularly when treating patients for which several treatment approaches may be appropriate because trial data does not clearly define the best option.Emerging therapeutic areas are evaluated, as work continues to identify agents that produce superior morphologic responses and visual acuity gains by targeting other molecules that contribute to diabetic retinopathy. Promising new drugs, targets and delivery systems are identified, and their development analysed. von Stewart, Michael
Produktdetails
So garantieren wir Dir zu jeder Zeit Premiumqualität.
Über den Autor
Michael W. Stewart, MD is Professor of Ophthalmology in the Mayo School of Medicine and for the past 10 years has served as Chairman of the Department of Ophthalmology at Mayo Clinic Florida.Dr. Stewart has published broadly on several vitreoretinal surgical conditions, infectious retinitis, and macular diseases. His primary research interests center on the pathophysiology and treatment of chorioretinal vascular conditions, and drug development. Dr. Stewart has published numerous manuscripts on ocular pharmacokinetics, pharmacodynamics, and the mathematical modeling of treatment responses. Dr. Stewart has authored 86 peer reviewed manuscripts, serves on the Editorial Boards of 5 journals, including as Associate Editor of the American Journal of Ophthalmology, and has performed peer-review for 70 other journals. During each of the past 4 years he has been an organizing member and primary author of a multi-city symposium on the treatment of macular diseases. For the 2015 educational series - Retinal Forum: Focus on Diabetic Retinopathy - Dr. Stewart authored and presented the introductory lecture "Pharmacology of Retinal Therapeutic Agents".
- hardcover
- 232 Seiten
- Erschienen 2003
- John Wiley & Sons
- Gebunden
- 289 Seiten
- Erschienen 2007
- Springer
- Kartoniert
- 281 Seiten
- Erschienen 2022
- Pabst Science Publishers
- paperback
- 88 Seiten
- Erschienen 2020
- American Diabetes Association
- hardcover
- 352 Seiten
- Erschienen 2018
- Mayo Clinic Press
- hardcover
- 130 Seiten
- Erschienen 2002
- Springer
- paperback
- 192 Seiten
- Erschienen 2005
- Books on Demand
- Gebunden
- 520 Seiten
- Erschienen 2012
- Thieme
- perfect -
- Erschienen 1975
- Thieme-Verlag
- spiral_bound
- 73 Seiten
- Erschienen 2002
- American Diabetes Association
- mass_market
- 271 Seiten
- Erschienen 1999
- Penguin Group USA
- hardcover
- 240 Seiten
- Erschienen 2025
- Elsevier
- Kartoniert
- 225 Seiten
- Erschienen 2022
- Urban & Fischer Verlag/Else...
- hardcover
- 316 Seiten
- Erschienen 2015
- Elsevier
- Kartoniert
- 223 Seiten
- Erschienen 2022
- W. Kohlhammer GmbH
- hardcover
- 176 Seiten
- Erschienen 2002
- KRAL




